Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30

$2.10−0.02 (-0.94%)

Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –

Compugen operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was 43.1%, against -53.4% the year before. The highest annual figure on record is 43.1% in fiscal 2025.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	43.1%	+96.5
FY2024	Dec 31, 2024	-53.4%	−14.6
FY2023	Dec 31, 2023	-38.8%	+432.8
FY2022	Dec 31, 2022	-471.7%	+112.9
FY2021	Dec 31, 2021	-584.6%	+990.2
FY2020	Dec 31, 2020	-1574.8%	−1444.3
FY2018	Dec 31, 2018	-130.5%	+4445.8
FY2016	Dec 31, 2016	-4576.3%	−4350.8
FY2015	Dec 31, 2015	-225.5%	−125.7
FY2014	Dec 31, 2014	-99.8%	+380.5
FY2013	Dec 31, 2013	-480.2%	+5115.6
FY2012	Dec 31, 2012	-5595.9%	−4889.3
FY2010	Dec 31, 2010	-706.5%	+2345.1
FY2009	Dec 31, 2009	-3051.6%	–